Inflammatory Bowel Disease Program
An estimated one million American men and women
currently suffer from inflammatory
bowel disease (IBD), a condition characterized
by inflammation of the gastrointestinal
(GI) tract.
Penn provides evaluation and
state-of-the-art treatment for two major types
of IBD, Crohn's
disease and ulcerative
colitis,
as well as refractory inflammatory bowel disease
and unexplained diarrhea.
The IBD program at Penn is home to one of the
largest groups in the world based at an academic
medical center focused on the care and research
of IBD. As the treatment of IBD evolves, Penn
is at the forefront of developing new therapies
and diagnostic techniques.
“Our
team of physicians with background
in epidemiology, basic science
and clinical trials is on the
forefront in the discipline of
inflammatory bowel disease. We
bridge the latest information
in the field of gastroenterology
with clinical care, providing
expert treatment for our patients.”
– Faten
N. Aberra, MD, MSCE
Assistant
Professor of Medicine
Penn Gastroenterology |
|
Diagnosis
To diagnose IBD, your physician takes your medical history and performs a full
medical examination, including blood tests and bowel movement samples. Other
tests may include:
- Flexible
Sigmoidoscopy or Colonoscopy – Your
physician inserts a small flexible tube into
the anus. The tube is slowly passed into
the lower third of the colon (flexible sigmoidoscopy)
or through the entire colon (colonoscopy),
allowing your physician to see the lining
of the colon. If necessary, he or she can
take a tissue sample to diagnose your condition.
- Barium
Enema – This is an X-ray of the
colon. A white substance called barium is
put into the colon by an enema. This test
may allow your doctor to see areas of the
colon that are abnormal.
- Small bowel X-ray (Crohn's disease
only)
In addition to standard testing, the extensive
resources at Penn provide physicians with a wide
array of tools for diagnosing GI problems, including endoscopic
retrograde cholangiopancreatograph, manometry,
breath testing and endoscopic
ultrasound (EUS).
Treatment
If you are diagnosed with ulcerative colitis or Crohn's disease, your physician
will discuss a treatment plan with you that may include medication or surgery,
along with nutrition planning and emotional support.
Medication
Currently, there is no cure for IBD, however,
medications are available that decrease the
inflammation of the colon lining and control
the symptoms of IBD. These medications can
relieve diarrhea, rectal bleeding and abdominal
pain, and allow the colon to heal.
Four major classes of medication are used today
to treat ulcerative colitis:
- Aminosalicylates (5-ASA) – Effective
in treating mild to moderate episodes of ulcerative
colitis, these medications are also useful
in preventing relapses of this disease. Examples
include sulfasalazine and oral formulations
of mesalamine (Asacol®, Colazal®,
Dipentum®, Pentasa®).
5-ASA drugs also may be administered rectally
(Canasa® and Rowasa®).
- Corticosteroids – Prednisone
and methylprednisolone nonspecifically suppress
the immune system, meaning they suppress the
entire immune system, not one particular area.
- Immune modifiers – Sometimes
called immunomodulators, these
medications are used to help decrease corticosteroid
dosage and patients' dependence on corticosteroids.
They also may help maintain remission in some
patients who do not respond to standard medications.
Examples include Azathioprine (Imuran®),
6-MP (Purinethol®), and methotrexate
Immune modifiers.
- Antibiotics
- Biologic therapies (Crohn's disease) – In
August 1998, the FDA approved infliximab (Remicade®),
the first biologic therapy for Crohn's disease.
This medication is used for moderately to severely
active Crohn's patients who have not responded
adequately to conventional therapy, or for
reducing the number of draining enterocutaneous
fistulas. This medication can also be used
to maintain remission.
Surgery
Surgery may be appropriate for patients who
do not respond to a treatment plan of medication
and nutritional planning. Based on the patient's
type of IBD and the extent of disease, options
for surgery include:
- Resection and Anastomosis – The
diseased segment of bowel and any associated
abscess are removed, and the two ends of healthy
bowel are joined together in a procedure called anastomosis.
- Proctocolectomy – The entire
colon and rectum are removed, with the creation
of an ileostomy, or external stoma (an opening
on the abdomen through which wastes are emptied
into a pouch that is attached to the skin with
adhesive).
- Restorative Proctocolectomy – This
procedure also calls for removal of the colon,
but it avoids an ileostomy. By creating an
internal pouch from the small bowel and attaching
it to the anal sphincter muscle, the surgeon
can preserve bowel integrity and eliminate
the need for the patient to wear an external
ostomy appliance.
Locations
This program is available at the following locations:
Perelman
Center for Advanced Medicine
Fourth Level, Suite 4-370S
3400 Civic Center Boulevard
Philadelphia, PA 19104
Driving
Directions
Penn
Presbyterian Medical Center
51 N. 39th Street
Wright-Saunders Building, Suite 218
Philadelphia, PA 19104
Driving
Directions
Penn Medicine Radnor
250 King of Prussia Road
Radnor, PA 19087
Driving
Directions
Sources:
Digestive System Illustration
Copyright A.D.A.M., Inc. |